NEW YORK (Reuters) - Eli Lilly said on Thursday U.S. regulators approved the use of Cymbalta, its blockbuster anti-depressant drug, for chronic musculoskeletal pain, including lower back pain and ...
NEW YORK (MarketWatch) -- Eli Lilly and Co. said Monday that the U.S. Food and Drug Administration has approved its Cymbalta drug for the management of fibromyalgia, a chronic widespread pain disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results